Valley Fever, A Regional Health Concern Health Journalism 2018 - - PowerPoint PPT Presentation

valley fever a regional health concern
SMART_READER_LITE
LIVE PREVIEW

Valley Fever, A Regional Health Concern Health Journalism 2018 - - PowerPoint PPT Presentation

Valley Fever, A Regional Health Concern Health Journalism 2018 April 15 th John N Galgiani MD Valley Fever Center for Excellence University of Arizona What Is Valley Fever? Caused by soil fungi Severity varies Mild: 60%


slide-1
SLIDE 1

Valley Fever, A Regional Health Concern

Health Journalism 2018 April 15th

John N Galgiani MD Valley Fever Center for Excellence University of Arizona

slide-2
SLIDE 2

Valley Fever Center for Excellence

What Is Valley Fever?

  • Caused by soil fungi

Coccidioides immitis Coccidioides posadasii

  • Other names:

– Coccidioidomycosis (cocci) – Desert Rheumatism

  • Infection results from

inhaling a spore

  • Severity varies

– Mild: 60% – Moderate: 30% – Complicated: 10%

  • After infection,

most (All?) persons develop life-long immunity to reinfection

slide-3
SLIDE 3

Valley Fever Center for Excellence

Spores of Coccidioides Spores of Anthrax

Sun SH. Ezzell J, USAMRIID

1μm

slide-4
SLIDE 4

Valley Fever Center for Excellence

slide-5
SLIDE 5

Valley Fever Center for Excellence

Valley Fever in the U.S.

150,000- 15,000- 1,500- 150- 15-

Total Infections Seek Medical Attention Diagnosed/Reported Disseminated Infection Deaths 75% Stopped working, Lost time > 2 weeks 50% Illness >6 months 40% Hospitalized Cost=$200M (2012) Total US Impact: $0.5B/year

slide-6
SLIDE 6

Valley Fever Center for Excellence

Impact: Polio vs Valley Fever

Rates per 100,000 Polio (1955) Coccidioides All Reported 18 20 Paralytic 1 Disseminated 1

slide-7
SLIDE 7

Valley Fever Center for Excellence

Impact: Polio vs Valley Fever

Rates per 100,000 Polio (1955) Coccidioides Population In billions World 7.5 AZ & CA only .04 All Reported 18 20 Paralytic 1 Disseminated 1

slide-8
SLIDE 8

Valley Fever Center for Excellence www.vfce.arizona.ed u

The Valley Fever Corridor: 2/3 of all reported U.S. disease occur here

slide-9
SLIDE 9

Valley Fever Center for Excellence

22nd Anniversary of the UA VFCE

  • Education

– 2002 Valley Fever Awareness Program

15th Annual Valley Fever Awareness Week November 11th – 19th 2017

slide-10
SLIDE 10

Valley Fever Center for Excellence

22nd Anniversary of the UA VFCE

  • Education

– 2002 Valley Fever Awareness Program – 2016 Primary Care Tutorial, 2nd Edition

slide-11
SLIDE 11

Valley Fever Center for Excellence

22nd Anniversary of the UA VFCE

  • Education

– 2002 Valley Fever Awareness Program – 2016 Primary Care Tutorial, 2nd Edition – CME Programs: Live and Online

  • New VFCE website, ATS, MedScape
slide-12
SLIDE 12

Valley Fever Center for Excellence

22nd Anniversary of the UA VFCE

  • Education

– 2002 Valley Fever Awareness Program – 2016 Primary Care Tutorial, 2nd Edition – CME Programs: Live and Online

  • New VFCE website, ATS, MedScape
  • Research

– $25-35 million in funding: Epi., Immunol., Genetics, Diagnostics, Drugs, Vaccines

  • Clinical Care (?)
slide-13
SLIDE 13

Valley Fever Center for Excellence

How bad is it?

Ariz CAP

– ~25%-30% due to Coccidioides BUT – <15% are tested for Coccidioides.

~1,000 new Az medical licenses/yr

– 12% received MD in Az; 40% no Az GME

80% didn’t know: VF is reportable; Vaccine does not exist 40% of clinicians not confident to treat VF

  • Chang, 2008; Chen, 2011
slide-14
SLIDE 14

Valley Fever Center for Excellence

Consequences of Current Standard Practices

  • Delays in diagnosis of early coccidioidal

infections: In BUMC-T, 30% > 1 month*

– Unnecessary anti-bacterial drug use – Protracted patient anxiety and fear – Over-utilization CT scans and bronchoscopies, even thoracotomies

  • Hypothesis: Earlier diagnosis would

improve outcomes and reduce cost.

*Donovan et al, Cocci Study Group 2018

slide-15
SLIDE 15

Valley Fever Center for Excellence

Clinical Network and Research

Vaccines

New Drugs (Nikkomycin Z) Better Diagnostics; Genetics of Risk Clinical Care/Clinical Platform; Do Better with the tools we have

slide-16
SLIDE 16

Valley Fever Center for Excellence

Valley Fever Costs

Educate patients and doctors $100 thousand/year Referral network and case management $300 thousand/year Diagnostic test development $1.5 million Nikkomycin Z development $40-$60 million Vaccine development

  • - Protein vaccine: $40 M

just to start clinical trials

  • - Live attenuated vaccine:

Safety????? Dogs then Humans. $??

Doing nothing

$ 0.5 Billion/yr

slide-17
SLIDE 17

Valley Fever Center for Excellence

Valley Fever Center for Excellence

Questions?